-
公开(公告)号:US20240254199A1
公开(公告)日:2024-08-01
申请号:US18489274
申请日:2023-10-18
发明人: Amy Shen , Inn Huam Yuk , Gavin Christian Barnard , Shahram Misaghi , Simon Auslaender , Niels Bauer , Benedikt Oswald
CPC分类号: C07K16/00 , C12N5/00 , C12N9/22 , C12N15/11 , C12N15/907 , C12P21/00 , C12N2310/20 , C12N2800/80
摘要: The present disclosure relates to mammalian cells (e.g., Chinese Hamster Ovary (CHO) cells) that are modified to reduce or eliminate the expression of certain mammalian cell endogenous products (e.g., host cell proteins and virus-like particles), and methods of using such cells in the production of a recombinant product of interest, e.g., a recombinant protein, a recombinant viral particle, or a recombinant viral vector. These modifications were specifically chosen to generate engineered mammalian host cells with desired traits in several key areas, including improved cell culture performance (e.g., higher viability and product titers), improved product quality (e.g., more consistent and favorable glycosylation; more stable drug product), and decreased burden on purification for removing problematic or undesired endogenous host cell products (e.g., hydrolytic host cell proteins and virus-like particles) during biomanufacturing.
-
公开(公告)号:US12030952B2
公开(公告)日:2024-07-09
申请号:US17664609
申请日:2022-05-23
发明人: Harald Duerr , Sebastian Fenn , Ulrich Goepfert , Sabine Imhof-Jung , Christian Klein , Laurent Lariviere , Michael Molhoj , Joerg Thomas Regula , Petra Rueger , Wolfgang Schaefer
CPC分类号: C07K16/2887 , A61P25/00 , C07K16/2881 , C07K2317/31 , C07K2317/515 , C07K2317/522 , C07K2317/55 , C07K2317/66 , C07K2317/92 , C07K2317/94
摘要: Herein are provided bispecific anti-human CD20/human transferrin receptor antibodies and methods of using the same.
-
23.
公开(公告)号:US20240216471A1
公开(公告)日:2024-07-04
申请号:US18516397
申请日:2023-11-21
发明人: Laura CODARRI DEAK , Douglas HANAHAN , Christian KLEIN , Valeria NICOLINI , Pablo UMANA , Stephan WULLSCHLEGER
CPC分类号: A61K38/2013 , A61K35/15 , A61K35/17 , A61K38/1774 , A61K39/3955 , A61P35/00
摘要: The present invention relates to the combination therapy of specific PD-1-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.
-
公开(公告)号:US20240207398A1
公开(公告)日:2024-06-27
申请号:US18423520
申请日:2024-01-26
发明人: Qingyuan LIU , Anila TAHIRI , Zhao ZHANG , Edward Namserk CHA
IPC分类号: A61K39/395 , A61K31/282 , A61K31/513 , A61K31/7068 , A61K38/17
CPC分类号: A61K39/3955 , A61K31/282 , A61K31/513 , A61K31/7068 , A61K38/1774
摘要: The invention provides methods and compositions for use in treating cancer, e.g., gastric cancer (e.g., a gastric carcinoma (GC) or a gastroesophageal junction carcinoma (GEJC) (e.g., inoperable, locally advanced, metastatic, or advanced GC or GEJC)) or rectal cancer (e.g., locally advanced rectal cancer (LARC)) in a subject, for example, by administering to the subject a treatment regimen that includes an anti-TIGIT antagonist antibody (e.g., tiragolumab) in combination with a PD-1 axis binding antagonist (e.g., atezolizumab). The treatment regimen may be administered with chemotherapy or following a neoadjuvant chemotherapy regimen. Also provided are compositions (e.g., compositions comprising a PD-1 axis binding antagonist (e.g., atezolizumab) and/or an anti-TIGIT antagonist antibody (e.g., tiragolumab), including pharmaceutical compositions thereof, kits thereof, and articles of manufacture thereof) for use in treating cancer, e.g., gastric cancer (e.g., a GC or a GEJC (e.g., inoperable, locally advanced, metastatic, or advanced GC or GEJC)) or rectal cancer (e.g., LARC) in a subject.
-
25.
公开(公告)号:US20240199585A1
公开(公告)日:2024-06-20
申请号:US18533710
申请日:2023-12-08
发明人: Bengt ÅSLUND , Manuel KONRATH , Ulf Goeran LARSSON , Johan Salman MALMBERG , Alexander Bogdan Emil MINIDIS , Isabelle Georgette Huguette MODOLO-CHELLAT
IPC分类号: C07D403/12 , A61K9/00 , A61K9/02 , A61K9/20 , A61K9/48 , A61K31/517 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/32 , A61K47/38
CPC分类号: C07D403/12 , A61K9/0019 , A61K9/009 , A61K9/02 , A61K9/2013 , A61K9/2018 , A61K9/2054 , A61K9/2059 , A61K9/4825 , A61K9/4858 , A61K9/4866 , A61K9/4875 , A61K31/517 , A61K47/10 , A61K47/12 , A61K47/26 , A61K47/32 , A61K47/38
摘要: The present invention provides solid forms of (3R)-N-[2-cyano-4-fluoro-3-(3-methyl-4-oxo-quinazolin-6-yl)oxy-phenyl]-3-fluoro-pyrrolidine-1-sulfonamide and solvates thereof, as well as therapeutic uses and processes to manufacture the new solid forms.
-
公开(公告)号:US20240199400A1
公开(公告)日:2024-06-20
申请号:US18572493
申请日:2022-08-14
发明人: Neil B. CAMMISH , Guido DREES
IPC分类号: B67B1/04
CPC分类号: B67B1/045
摘要: A closure processing equipment for closing openings of a number of containers includes a number of stopper members, a container holder and a set of compensation structures. Each of the stopper members is made of an elastic material, has a plug portion configured to fit into an opening of one of the number of containers and has a cover portion configured to abut a boundary surface adjacent to the opening of the one of the number of containers. The container holder has a number of container seats each configured to receive one of the number of containers in a predefined position. Each compensation structure of the set of compensation structures is configured to compensate a container manufacturing dimension tolerance. The set of compensation structures includes diverse compensation structures to compensate different container manufacturing dimension tolerances.
-
公开(公告)号:US12012390B2
公开(公告)日:2024-06-18
申请号:US17275502
申请日:2019-09-11
发明人: Song Feng , Chungen Liang , Yongfu Liu , Hong Shen , Xuefei Tan , Jun Wu , Dongdong Chen , Chao Li , Li Wang
IPC分类号: C07D311/30 , A61P31/20 , C07D335/06 , C07D405/04
CPC分类号: C07D311/30 , A61P31/20 , C07D335/06 , C07D405/04
摘要: The present invention provides flavone derivatives having the general formula (I) which are useful for the treatment of Hepatitis B Virus infection (HBV). The compounds act as cccDNA (covalently closed circular DMA) inhibitors.
-
公开(公告)号:US20240194298A1
公开(公告)日:2024-06-13
申请号:US18581036
申请日:2024-02-19
发明人: Lito Kriara , Florian Lipsmeier , Mattia Zanon
摘要: A computer implemented method for classifying quality of biological sensor data (110) comprising the following steps:
providing biological sensor data (110) obtained by at least one biological sensor (112), wherein the biological sensor data (110) comprises at least one signal (116);
classifying quality of the signal (116) by using at least one trained trainable model (119), wherein the trainable model (119) is trained on historical biological sensor data based on a supervised (134) and/or semi-supervised deep learning architecture (188), wherein the trainable model (119) is trained by optimizing one loss function in terms of classification or two loss functions in terms of signal reconstruction and classification.
Further, a biological sensor (112), a computer program and a computer-readable storage medium are disclosed.-
29.
公开(公告)号:US20240190889A1
公开(公告)日:2024-06-13
申请号:US18429832
申请日:2024-02-01
发明人: Giuseppe CECERE , Luca GOBBI , Maria-Clemencia HERNANDEZ , Andreas KOBLET , Andres Miguel OLIVARES MORALES , Valerie RUNTZ-SCHMITT , Nicolas ZORN
IPC分类号: C07D495/14 , A61K31/551
CPC分类号: C07D495/14 , A61K31/551
摘要: The invention provides heterocyclic compounds having the general formula (1), and pharmaceutically acceptable salts thereof, wherein the variables are as described herein.
Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds for the treatment or prevention of acute neurological disorders, chronic neurological disorders and/or cognitive disorders. release wednesday-
公开(公告)号:US20240182493A1
公开(公告)日:2024-06-06
申请号:US18369140
申请日:2023-09-15
IPC分类号: C07D519/00 , C07D487/04
CPC分类号: C07D519/00 , C07D487/04
摘要: The present invention relates to a process for the preparation of 7-(4.7-diazaspiro[2.5]octan-7-vl)-2-(2.8-dimethylimidazo[1.2-b]pyridazin-6-vl)pyrido[1.2-a]pyrimidin-4-one derivatives useful as pharmaceutically active compounds.
-
-
-
-
-
-
-
-
-